Dudediligence.

Acurx Pharmaceuticals, Inc

ACXPNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$2.8MSep ’24−$2.8MDec ’24−$2.1MMar ’25−$2.2MJun ’25−$2.0MSep ’25−$1.6MDec ’25−$1.7MMar ’26−$2.3MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating incomenone on filenone on filenone on file−$14.1M−$8.1M
Net income−$12.7M−$12.1M−$14.6M−$14.1M−$8.0M
Operating cash flow−$5.0M−$7.5M−$9.8M−$10.4M−$6.8M
Cash$13.0M$9.1M$7.5M$3.7M$7.6M
Shares outstanding10.2M11.6M14.5M851.5K2.3M